Notice Pursuant to the National Cooperative Research and Production Act of 1993-UHD Alliance, 104209 [2024-30412]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
Wilmington, DE; Serimmune, Goleta,
CA; UNITED KINGDOM HEALTH
SECURITY AGENCY (UKHSA),
Salisbury, UNITED KINGDOM;
University of Connecticut, Farmington,
CT; VGXI, Inc., Conroe, TX; ABSS
Solutions, Inc., Upper Marlboro, MD;
BiosYnth SRL, Milan, ITALY; Idevax,
Wijnegem, BELGIUM; IntegerBio, Inc.,
Gaithersburg, MD; Phoreus
Biotechnology, Inc., Olathe, KS;
PrecNA, LLC, North Potomac, MD;
Sepragen Corp., Union City, CA; Trellis
Bioscience, Inc., Redwood City, CA; AB
Validation, Inc., Quebec, CANADA;
AuraVax Therapeutics, Inc., Houston,
TX; CuriRx, Inc., Wilmington, MA; IMA
Evaluations, LLC, dba IMA Clinical
Research, Tarrytown, NY; MustardSeed
PMO, West Chester, PA; Symbiosis.io,
LLC, Smyrna, GA; Tornado
Therapeutics, Boston, MA; Amneal
Pharmaceuticals of New York, LLC,
Brookhaven, NY; Blue Spark
Technologies, Inc., Westlake, OH;
Inhalon Biopharma, Inc., Morrisville,
NC; Intelligene, Inc., Taipei, TAIWAN;
Rocket Science Health US Corp., Seattle,
WA; Rutgers, The State University of
New Jersey, Piscataway, NJ; The
Administrators of the Tulane
Educational Fund, New Orleans, LA;
Verisim Life, Inc., San Francisco, CA;
Arcturus Therapeutics Holdings, Inc.,
San Diego, CA; Blu Zone Bioscience &
Supply Chain Solutions, LLC, Frederick,
MD; Elligo Health Research, Inc.,
Austin, TX; Guide Biomedical
Solutions, LLC, Media, PA; Integral
Molecular, Philadelphia, PA; Komo
Biosciences, Inc., Newton, MA; P95, BV,
Leuven, BELGIUM; Southwest Research
Institute, San Antonio, TX; Statistics &
Data Corp., Tempe, AZ; Stoic Bio, Inc.,
San Diego, CA; Valaria Technical
Consultants, LLC, Westminster, MD;
Vaxine Pty, Ltd., Marion, AUSTRALIA;
Zeteo Biomedical, LLC, Austin, TX;
Concept to Market, LLC, Monrovia, MD;
DSBio Consulting, LLC, Annapolis, MD;
Deimos Biosciences, San Francisco, CA;
GMED North America, Inc., Rockville,
MD; InvisiShield Technologies, Ltd.,
Emeryville, CA; MigVax, Ltd., Kiryat
Shmona, ISRAEL; Polaris Alpha
Advanced Systems, Inc.,
Fredericksburg, VA; Pop Test Oncology,
LLC, Cliffside Park, NJ; Sapphiros,
Boston, MA; Articulate Labs, Inc.,
Dallas, TX; Empatica, Inc., Cambridge,
MA; LifeMine Therapeutics, Inc.,
Cambridge, MA; Luminous
Therapeutics Corp., Columbia, MD;
Nabla Bio, Inc., Cambridge, MA;
Qoolabs, Inc., Carlsbad, CA; Rapid
Novor, Inc., Kitchener, CANADA;
Scorpius BioManufacturing, San
Antonio, TX; Sunflower Therapeutics
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
PBC, Medford, MA; GreenRoads
Diagnostics, Inc., San Diego, CA; Logical
Images, dba ‘‘VisualDx’’, Rochester, NY;
Mirai Biosciences, Cambridge, MA; The
Scripps Research Institute, La Jolla, CA;
AmplifyBio, LLC, West Jefferson, OH;
Andelyn Biosciences, Inc., Columbus,
OH; Binary Pharmaceuticals, LLC, Hot
Springs, AR; BioCina PTY, Ltd., West
Torrens, AUSTRALIA; Cypress
Biologics, LLC, Portland, OR; Fermeate,
Inc., San Francisco, CA; HMH Hospitals
Corp, dba CDI, Nutley, NJ; Meso Scale
Diagnostics, LLC, Rockville, MD;
Systems & Technology Research, LLC,
Woburn, MA; Telesis Bio, San Diego,
CA; Thermo Fisher, South San
Francisco, CA; University of
Massachusetts Lowell, Lowell, MA;
ViQi, Inc., Santa Barbara, CA;
DemeTech Corp., Miami, FL; INFEX
Therapeutics, Alderley Edge, UNITED
KINGDOM; Mercury Bio, Inc., Santa Fe,
NM; Phageolytix, Inc., Jacksonville, FL;
Phenom Pharmaceuticals, LLC, Miami
Beach, FL; RIBOPRO BV, Oss,
NETHERLANDS; RNhale GmbH,
Munich, GERMANY; The University of
Chicago Medicine, Chicago, IL; Bioblue
CMC/Manufacturing Consulting, LLC,
San Diego, CA; Oligo Foundry, Inc., San
Diego, CA; PNUVAX, Inc., Wilmington,
DE; Prosoft Software, Inc., dba Prosoft
Clinical, Chesterbrook, PA; Simon
Williams Pharma Consulting (SWPC),
LLC, Gibbsboro, NJ; Dillico, Meylan,
FRANCE; INFINIFLUIDICS,
Philadelphia, PA; Primrose Bio, Inc.,
San Diego, CA; SIMETRI, Inc., Winter
Park, FL; The Trustees of the University
of Pennsylvania, Philadelphia, PA; and
WCG, Princeton, NJ, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and RRPV intends
to file additional written notifications
disclosing all changes in membership.
On January 5, 2024, RRPV filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on April 16, 2024 (89 FR 26928).
The last notification was filed with
the Department on July 11, 2024. The
Department of Justice published a notice
in the Federal Register pursuant to
section 6(b) of the Act on October 11,
2024 (89 FR 82631).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–30403 Filed 12–19–24; 8:45 am]
BILLING CODE P
PO 00000
Frm 00138
Fmt 4703
Sfmt 4703
104209
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance
Notice is hereby given that, on
October 8, 2024, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), UHD Alliance,
Inc. (‘‘UHD Alliance’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, TTE Corporation,
Shenzhen, PEOPLE’S REPUBLIC OF
CHINA has been added as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership.
On June 17, 2015, UHD Alliance filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on July 17, 2015 (80 FR
42537).
The last notification was filed with
the Department on July 8, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on September 26, 2024 (89 FR
78904).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–30412 Filed 12–19–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Subcutaneous Drug
Development & Delivery Consortium,
Inc.
Notice is hereby given that, on
October 4, 2024, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), Subcutaneous
Drug Development & Delivery
E:\FR\FM\20DEN1.SGM
20DEN1
Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Page 104209]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30412]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--UHD Alliance
Notice is hereby given that, on October 8, 2024, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), UHD Alliance, Inc. (``UHD
Alliance'') filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing changes in
its membership. The notifications were filed for the purpose of
extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, TTE Corporation, Shenzhen, PEOPLE'S REPUBLIC OF CHINA has
been added as a party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and UHD Alliance intends to file
additional written notifications disclosing all changes in membership.
On June 17, 2015, UHD Alliance filed its original notification
pursuant to section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to section 6(b) of
the Act on July 17, 2015 (80 FR 42537).
The last notification was filed with the Department on July 8,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on September 26, 2024 (89 FR 78904).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-30412 Filed 12-19-24; 8:45 am]
BILLING CODE P